NEOMYCIN SULFATE Drug Patent Profile
Which patents cover Neomycin Sulfate, and what generic alternatives are available?
Neomycin Sulfate is a drug marketed by Amvika, Bristol Myers Squibb, Chartwell Molecular, Lannett, Lilly, Pharmobedient, Roxane, Sandoz, Teva, Bausch And Lomb, Pharmafair, Alcon Pharms Ltd, Fougera, and Pharmaderm. and is included in twenty NDAs.
The generic ingredient in NEOMYCIN SULFATE is neomycin sulfate; triamcinolone acetonide. There are five drug master file entries for this compound. Additional details are available on the neomycin sulfate; triamcinolone acetonide profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for NEOMYCIN SULFATE?
- What are the global sales for NEOMYCIN SULFATE?
- What is Average Wholesale Price for NEOMYCIN SULFATE?
Summary for NEOMYCIN SULFATE
| US Patents: | 0 |
| Applicants: | 14 |
| NDAs: | 20 |
| Finished Product Suppliers / Packagers: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 90 |
| Clinical Trials: | 12 |
| Patent Applications: | 643 |
| DailyMed Link: | NEOMYCIN SULFATE at DailyMed |
Recent Clinical Trials for NEOMYCIN SULFATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Universitt Luzern | PHASE4 |
| Huro Biotech Joint Stock Company | N/A |
| Vietstar Biomedical Research | N/A |
Pharmacology for NEOMYCIN SULFATE
| Drug Class | Aminoglycoside Antibacterial |
Medical Subject Heading (MeSH) Categories for NEOMYCIN SULFATE
Anatomical Therapeutic Chemical (ATC) Classes for NEOMYCIN SULFATE
US Patents and Regulatory Information for NEOMYCIN SULFATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amvika | NEOMYCIN SULFATE | neomycin sulfate | TABLET;ORAL | 065220-001 | Jul 28, 2006 | AA | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Fougera | NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE | neomycin sulfate; triamcinolone acetonide | OINTMENT;TOPICAL | 062608-001 | May 23, 1986 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Roxane | NEOMYCIN SULFATE | neomycin sulfate | TABLET;ORAL | 062173-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
